EPH93 Traceability of Infliximab Reference Medicinal Product and Its Biosimilar Products Adverse Drug Events Reports in Saudi Arabia
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.975
https://www.valueinhealthjournal.com/article/S1098-3015(23)01075-6/fulltext
Section Title :
Section Order :
10431
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01075-6&doi=10.1016/j.jval.2023.03.975